IN
INSP.US Inspire Medical Systems Inc
- Market cap
- USD 1.77B
- P/E
- 18.2x
- P/B
- 2.14x
- ROE
- -5.7%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.
Is INSP.US undervalued?
Graham numberINSP.US trades 31.7% above its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Inspire Medical Systems Inc fundamental analysis
No fundamental analysis for Inspire Medical Systems Inc yet.
Inspire Medical Systems Inc stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Inspire Medical Systems Inc
Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for patients with moderate to severe OSA. It also develops a novel, closed-loop solution that continuously monitors a patient's breathing…
Full company profileInspire Medical Systems Inc financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Inspire Medical Systems Inc annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 16.4M | 28.6M | 50.6M | 82.1M | 115M | 233M | 408M | 625M | 803M | 912M | 816M |
| Gross Profit | 12.5M | 22.5M | 40.5M | 68.4M | 97.8M | 200M | 342M | 528M | 680M | 779M | 702M |
| Operating Income | -17.3M | -16.0M | -20.4M | -34.9M | -56.2M | -39.9M | -47.6M | -40.3M | 36.1M | 51.0M | -40.5M |
| EBITDA | -17.1M | -15.5M | -18.1M | -29.7M | -54.1M | -38.6M | -40.7M | -40.3M | 65.0M | 79.8M | -11.0M |
| Net Income | -18.5M | -17.5M | -21.8M | -33.2M | -57.2M | -42.0M | -44.9M | -21.2M | 53.5M | 145M | -47.2M |
| EPS | -1.49 | -1.30 | -1.50 | -1.40 | -2.19 | -1.54 | -1.60 | -0.72 | 1.75 | 4.89 | -1.63 |
| Balance Sheet | |||||||||||
| Total Assets | 13.1M | 25.1M | 200M | 181M | 281M | 295M | 565M | 677M | 808M | 907M | 953M |
| Total Liabilities | 19.7M | 23.6M | 36.1M | 41.4M | 51.4M | 66.0M | 68.9M | 104M | 119M | 126M | 126M |
| Shareholders' Equity | -6.61M | 1.48M | 164M | 140M | 230M | 229M | 496M | 573M | 690M | 781M | 827M |
| Cash & Short-term Investments | 6.69M | 16.1M | 188M | 149M | 234M | 214M | 451M | 460M | 446M | 308M | 328M |
| Total Debt | 15.7M | 16.5M | 24.9M | 25.4M | 30.6M | 34.1M | 16.4M | 24.8M | 31.8M | 32.2M | 28.6M |
| Cash Flow | |||||||||||
| Operating Cash Flow | -17.9M | -15.8M | -18.7M | -33.4M | -53.0M | -20.1M | 11.6M | 24.7M | 130M | 117M | 110M |
| Capital Expenditure | 306K | 412K | 250K | 2.74M | 2.46M | 4.67M | 9.10M | 23.6M | 39.1M | 38.5M | 35.2M |
| Free Cash Flow | -18.3M | -16.2M | -18.9M | -35.6M | -55.5M | -24.8M | 2.47M | 1.02M | 91.1M | 78.5M | 74.8M |
| Ratios | |||||||||||
| ROE | - | -1,180.0% | -13.3% | -23.8% | -24.9% | -18.4% | -9.0% | -3.7% | 7.8% | 18.6% | -5.7% |
| ROA | -141.3% | -69.8% | -10.9% | -18.3% | -20.3% | -14.2% | -7.9% | -3.1% | 6.6% | 16.0% | -4.9% |
| Net Profit Margin | -112.8% | -61.3% | -43.1% | -40.5% | -49.6% | -18.0% | -11.0% | -3.4% | 6.7% | 15.9% | -5.8% |
| Debt to Equity | - | 11.09x | 0.15x | 0.18x | 0.13x | 0.15x | 0.03x | 0.04x | 0.05x | 0.04x | 0.03x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Inspire Medical Systems Inc dividends
Inspire Medical Systems Inc has not paid dividends in the last 9 fiscal years.
Who owns Inspire Medical Systems Inc
- Insiders 7.50%
- Institutions 92.50%
- Public & others 0.00%
- Shares outstanding 29.0M
- Free float 25.3M
Top funds holding INSP.US
| Holder | Shares | % of shares | Change | As of |
|---|---|---|---|---|
| Vanguard Health Care Inv | 2.09M | 7.23% | 0.00% | Sep 2026 |
| iShares Core S&P Small-Cap ETF | 1.74M | 6.00% | -0.15% | Oct 2026 |
| Vanguard MStar Total Stk Mkt Idx Invest | 916K | 3.16% | +0.23% | Sep 2026 |
| iShares Russell 2000 ETF | 736K | 2.54% | 0.00% | Oct 2026 |
| Vanguard Small Cap Index | 651K | 2.25% | -1.71% | Sep 2026 |
| Artisan International Small-Mid Investor | 525K | 1.81% | +15.22% | Sep 2026 |
| Vanguard MStar Small Cap Growth Indx Inv | 362K | 1.25% | -4.51% | Sep 2026 |
| Fidelity Small Cap Index | 318K | 1.10% | +0.15% | Aug 2026 |
| State Street SPDR Port S&P 600 Sm CpETF | 265K | 0.92% | -0.05% | Oct 2026 |
| iShares S&P Small-Cap 600 Growth ETF | 260K | 0.90% | -0.40% | Oct 2026 |
| Federated Hermes MDT Mid Cap Growth A | 237K | 0.82% | 0.00% | Sep 2026 |
| iShares Russell 2000 Growth ETF | 236K | 0.81% | -0.38% | Oct 2026 |
| Principal US Small Cap ETF | 180K | 0.62% | +0.05% | Oct 2026 |
| Vanguard Russell 2000 ETF | 169K | 0.58% | +1.12% | Sep 2026 |
| State Street® SPDR® S&P 600™ Sm Cp GrETF | 164K | 0.57% | 0.00% | Oct 2026 |
| Schwab US Small-Cap ETF™ | 153K | 0.53% | +0.23% | Oct 2026 |
| William Blair Small Cap Growth I | 150K | 0.52% | 0.00% | Sep 2026 |
| Vanguard Explorer Inv | 140K | 0.48% | -23.19% | Sep 2026 |
| iShares US Medical Devices ETF | 138K | 0.48% | -1.12% | Oct 2026 |
| Fidelity Extended Market Index | 134K | 0.46% | +4.17% | Sep 2026 |
Top institutions holding INSP.US
| Holder | Shares | % of shares | Change | As of |
|---|---|---|---|---|
| BlackRock Inc | 4.74M | 16.36% | +33.47% | Jun 2026 |
| Wellington Management Company LLP | 2.38M | 8.23% | -6.04% | Jun 2026 |
| Vanguard Portfolio Management, LLC | 2.09M | 7.21% | +27.60% | Jun 2026 |
| Soleus Capital Management, L.P. | 1.93M | 6.67% | +235.14% | Jun 2026 |
| AQR Capital Management LLC | 1.86M | 6.41% | +501.56% | Jun 2026 |
| Assenagon Asset Management SA | 1.73M | 5.97% | +232.35% | Jun 2026 |
| UBS Group AG | 1.65M | 5.68% | +157.54% | Jun 2026 |
| D. E. Shaw & Co LP | 1.47M | 5.08% | +23.72% | Jun 2026 |
| Nomura Holdings Inc | 1.37M | 4.73% | 0.00% | Jun 2026 |
| Deerfield Management Co | 1.30M | 4.48% | -52.03% | Jun 2026 |
| Vanguard Capital Management, LLC | 1.27M | 4.39% | +0.33% | Jun 2026 |
| State Street Corp | 1.21M | 4.17% | +26.20% | Jun 2026 |
| Morgan Stanley - Brokerage Accounts | 791K | 2.73% | -45.46% | Jun 2026 |
| Artisan Partners Limited Partnership | 732K | 2.53% | -6.18% | Jun 2026 |
| Geode Capital Management, LLC | 701K | 2.42% | +37.36% | Jun 2026 |
| BRAIDWELL LP | 678K | 2.34% | 0.00% | Jun 2026 |
| The Goldman Sachs Group Inc | 646K | 2.23% | -2.73% | Jun 2026 |
| UBS Asset Mgmt Americas Inc | 546K | 1.89% | +21.67% | Jun 2026 |
| Nantahala Capital Management, LLC | 539K | 1.86% | 0.00% | Jun 2026 |
| Citadel Advisors Llc | 506K | 1.75% | +28.49% | Jun 2026 |
Inspire Medical Systems Inc company profile
- Company name
- Inspire Medical Systems Inc
- Ticker
- INSP.US
- Exchange
- USA Stocks
- Listed since
- May 3, 2018
- Sector
- Healthcare
- Industry
- Health Care Technology
- Employees
- 1,333
- Fiscal year end
- December
- Address
- 5500 Wayzata Blvd., Golden Valley, MN, United States, 55416
- Phone
- 844 672 4357
- Website
- inspiresleep.com
About Inspire Medical Systems Inc
Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for patients with moderate to severe OSA. It also develops a novel, closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.
Inspire Medical Systems Inc management
10- Mr. Timothy P. HerbertFounder, Chairman, CEO & President · born 1963
- Mr. Bryan K. Phillips J.D.Senior VP, General Counsel, Chief Compliance Officer & Corporate Secretary · born 1971
- Mr. Carlton W. WeatherbyChief Strategy and Growth Officer · born 1985
- Mr. Matthew J. OsbergExecutive VP & CFO · born 1977
- Mr. Jason P. KellyChief Operations & Innovation Officer · born 1980
- Ms. Melissa J. MannChief People Officer · born 1976
- Mr. Ivan LubogoSVP of Strategic Sales
- Mr. Andreas HenkeExecutive VP International & MD
- Mr. Joseph E. SanderSenior Vice President of U.S. Sales
- Ms. Megan Rowekamp CPADirector of Financial Reporting